BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25811121)

  • 1. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
    Sims OT; Womack BG
    Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Wyles DL; Sulkowski MS; Dieterich D
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S3-S11. PubMed ID: 27363438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coinfection with HIV and HCV: more questions than answers?
    Waldrep TW; Summers KK; Chiliade PA
    Pharmacotherapy; 2000 Dec; 20(12):1499-507. PubMed ID: 11130222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment options for hepatitis C patients co-infected with HIV.
    Rockstroh JK; Hardy WD
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):689-95. PubMed ID: 26799571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-CĂ©ron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
    Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    MacBrayne CE; Kiser JJ
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S12-23. PubMed ID: 27363437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/HCV Coinfection in Taiwan.
    Hsu CS; Kao JH
    AIDS Rev; 2016; 18(4):193-197. PubMed ID: 27438579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.
    Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T
    AIDS Patient Care STDS; 2019 May; 33(5):197-206. PubMed ID: 31067123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.
    Strader DB
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S7-13. PubMed ID: 16265618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV.
    Cachay ER; Torriani FJ; Hill L; Jain S; Del Real A; Qin H; Martin N; Mathews WC
    AIDS; 2020 Sep; 34(11):1681-1683. PubMed ID: 32769765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
    Easterbrook P; Sands A; Harmanci H
    Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the management of HIV/HCV coinfection.
    Mandorfer M; Schwabl P; Steiner S; Reiberger T; Peck-Radosavljevic M
    Hepatol Int; 2016 May; 10(3):424-35. PubMed ID: 26758592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels.
    Zhao A; Wegener M; Brooks R; Mininberg L; Helou E; Maughan A; Villanueva M
    Health Promot Pract; 2023 Sep; 24(5):1029-1038. PubMed ID: 37439687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.